CEBP:XETRA:XETRA-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (EUR)

ETF | Others |

Last Closing

USD 10.52

Change

0.00 (0.00)%

Market Cap

USD 0.20B

Volume

285.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.38 (+0.84%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.44 (-0.44%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.16 (+0.66%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.01 (+0.09%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.01 (+0.18%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.01 (+0.04%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.09 (-0.70%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.99 (+1.75%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.05 (-0.46%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.09 (-0.07%)

USD 12.26B

ETFs Containing CEBP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.74% 80% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.74% 82% B 75% C
Trailing 12 Months  
Capital Gain 9.22% 74% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.22% 75% C 72% C
Trailing 5 Years  
Capital Gain 104.43% 91% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 104.43% 91% A- 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.32% 86% B+ 84% B
Dividend Return 15.32% 86% B+ 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.90% 62% D 70% C-
Risk Adjusted Return 154.75% 100% F 99% N/A
Market Capitalization 0.20B 52% F 41% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike